Citi Starts Puma Biotechnology (PBYI) at Buy
Tweet
Share
E-mailGet Alerts PBYI Hot Sheet
Price: $7.02 --0%
Rating Summary:
5 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 26
Rating Summary:
5 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 26
Join SI Premium – FREE
Citi initiated coverage on Puma Biotechnology (NYSE: PBYI) with a Buy rating and a price target of $123.00.
For an analyst ratings summary and ratings history on Puma Biotechnology click here. For more ratings news on Puma Biotechnology click here.
Shares of Puma Biotechnology closed at $73.37 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Roth/MKM on Daktronics (DAKT) in new coverage comment: 'trends are supported by record participation in high school sports'
- TD Cowen Starts NervGen Pharma Corp (NGEN) at Buy, 'A New Generation In Spinal Cord Injury Treatment Is Here'
- Macquarie Starts Siemens Energy India (ENRIN:IN) at Outperform
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
